Orthofix Medical Reports the US FDA’s Clearance of Fitbone Transport and Lengthening System
Shots:
- The US FDA has granted 510(k) clearance to the company’s Fitbone Transport and Lengthening System that supports and lengthens the bone in a single surgery
- The device is intended for treating large bone defects in the femur and tibia due to trauma, infectious or malignant conditions
- The device employs motorized technology from the Fitbone TAA Intramedullary Lengthening System. It is a minimally invasive procedure comprising a motorized intramedullary nail, receiver, and external control set that allows patients to regulate the distraction phase at home; nail and receiver are removed after treatment
Ref: Orthofix | Image: Orthofix
Related News:- Orthofix Medical Signs a License Agreement with LimaCorporate to Provide Novel Solution for High Hip Dislocation in the US
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
